Zobrazeno 1 - 7
of 7
pro vyhledávání: '"John Andrew Livingston"'
Autor:
Qingnan Zhao, Jiemiao Hu, Abhisek Mitra, Jeffry Cutrera, Wendong Zhang, Zhongting Zhang, Jun Yan, Xueqing Xia, Kris Michael Mahadeo, John Andrew Livingston, Richard Gorlick, Shulin Li
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Background Although accumulated evidence provides a strong scientific premise for using immune profiles to predict survival in patients with cancer, a universal immune profile across tumor types is still lacking, and how to achieve a surviva
Externí odkaz:
https://doaj.org/article/4bc1fc5e21a741b6b075c03a5520d299
Autor:
Danh Truong, Salah-Eddine Lamhamedi-Cherradi, Mayinuer Maitituoheti, Hannah C. Beird, Emre Arslan, Chia-Chin Wu, Sandhya Krishnan, Davis Ingram, P Andrew Futreal, Mark Titus, Kunal Rai, Alexander Lazar, A Robert MacLeod, Ravin Ratan, John Andrew Livingston, Najat Daw, Andrea Hayes-Dixon, Joseph Ludwig
Publikováno v:
Cancer Research. 83:1196-1196
Desmoplastic small round cell tumor (DSRCT) is a rare, usually incurable, aggressive sarcoma subtype that occurs predominantly in adolescent and young adult (AYA) males. At diagnosis, most present with hundreds of intraabdominal nodules composed of m
Autor:
Neeta Somaiah, Anthony P Conley, Edwin Roger Parra, Heather Lin, Behrang Amini, Luisa Solis Soto, Ruth Salazar, Carmelia Barreto, Honglei Chen, Swati Gite, Cara Haymaker, Elise F Nassif, Chantale Bernatchez, Akash Mitra, John Andrew Livingston, Vinod Ravi, Dejka M Araujo, Robert Benjamin, Shreyaskumar Patel, Maria A Zarzour, Sharjeel Sabir, Alexander J Lazar, Wei-Lien Wang, Najat C Daw, Xiao Zhou, Christina L Roland, Zachary A Cooper, Jaime Rodriguez-Canales, Andrew Futreal, Jean-Charles Soria, Ignacio I Wistuba, Patrick Hwu
Publikováno v:
The Lancet. Oncology. 23(9)
Few standard treatment options are available for patients with metastatic sarcomas. We did this trial to evaluate the efficacy, safety, and changes in the tumour microenvironment for durvalumab, an anti-PD-L1 drug, and tremelimumab, an anti-CTLA-4 dr
Autor:
Whittney S. Thoman, Amy M. Berkman, Therese B. Bevers, John Andrew Livingston, Michael Roth, Susan C. Gilchrist
Publikováno v:
Medicine & Science in Sports & Exercise. 54:1-1
Autor:
Amanda, Parkes, Wei-Lien, Wang, Shreyaskumar, Patel, Cheuk Hong, Leung, Heather, Lin, Anthony P, Conley, Neeta, Somaiah, Dejka M, Araujo, Maria, Zarzour, John Andrew, Livingston, Joseph, Ludwig, Christina L, Roland, Vinod, Ravi, Robert S, Benjamin, Ravin, Ratan
Publikováno v:
Breast cancer research and treatment. 186(3)
Metastatic phyllodes tumors of the breast (MPT) are rare breast neoplasms, limiting development of standardized treatment approaches. We sought to characterize the largest group of MPT thus far reported, evaluating systemic therapy outcomes.Adult pat
Autor:
Jiemiao Hu, Wendong Zhang, Xueqing Xia, Qing Yang, Yuhui Chen, Natalie W Fowlkes, John Andrew Livingston, Zhongting Zhang, Kris M Mahadeo, Jonathan B Gill, Gianpietro Dotti, Scott Kopetz, Richard Gorlick, Shulin Li
Publikováno v:
The Journal of Immunology. 204:239.1-239.1
Adoptive transfer of genetic engineered T cells becomes an effective approach in treating hematologic malignancies, but shows poor responses against solid tumors due to multifactorial reasons. Interleukin-12 exhibits robust T cell activating and anti
Autor:
John P. Chute, Ashley Morris, Paul Szabolcs, Nelson J. Chao, Gregory D. Sempowski, Lun Wei Chiou, John Andrew Livingston, Donna Niedzwiecki, Keith M. Sullivan, Mitchell E. Horwitz, Cristina Gasparetto, Gwynn D. Long, Jacalyn McPherson, David A. Rizzieri, Junya Kanda, Gloria Broadwater, Jeffrey Hale
Publikováno v:
Biology of Blood and Marrow Transplantation. 18(11):1664-1676.e1
Immunologic reconstitution after allogeneic hematopoietic cell transplantation is a critical component of successful outcome. Umbilical cord blood (UCB) transplantation in adult recipients is associated with slow and often inadequate immune recovery.